To determine the potential clinical relevance of our in vivo findings we quantified β3‐AR expression via immunohistochemistry (IHC) in human normal (Figure 4a, CTRL a‐b) and ADPKD (Figure 4a,c,d) kidney samples. This evidence concerns the gene ADRB3 and autosomal dominant polycystic kidney disease.